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MICROBIAL PERSISTENCE* *
A number of animal species use the defense tactic of "playing dead" when
confronted with a hostile threat. It is the purpose of the present discussion
to develop the theme that "playing dead" is not limited to the more organ-
ized living creatures. For the adaptive plasticity of microbes to environ-
mental influences is such that, in a sense, they too can "play dead" when
menaced by an antimicrobial drug.
When a group of patients with a drug-susceptible infection is treated
with the appropriate antimicrobial drug, there is a rapid disappearance of
all evidences of illness, and the patients are apparently well. In the major-
ity of the patients this apparent absence of infection is permanent. In
others, a small subgroup indistinguishable from the rest, the illness reap-
pears after a treatment-free interval. The microorganisms isolated at the
time of this reappearance of illness are not drug-resistant in the usual sense,
and retreatment with the drug used originally is generally effective. This
capacity of drug-susceptible microorganisms to survive drug attack when
subsisting in an animal body may be designated as microbial persistence.
In the broad sense the term microbial persistence simply indicates some-
thing we all know, namely, that microbes have the ability to survive in this
perilous world. In the present discussion the term is used in a more narrow
sense, however, to designate the survival of microbes in a certain set of
definable circumstances. Employed in this way the term microbial per-
sistence describes a phenomenon whereby microorganisms which are drug-
susceptible when tested outside the body are nevertheless capable of surviv-
ing within the body despite intensive therapy with the appropriate anti-
microbial drug. In clinical practice this phenomenon obviously has to do
with the post-treatment "carrier state" and with post-treatment relapse. In
short, it is this phenomenon which is responsible for our inability to
eradicate an infection from a person or a community by the use of drugs.
The initial mention of this phenomenon as something which can be
observed in a "group of patients" was intentional. For the clinician does
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not usually encounter his patients as a group, all with the same infection.
Instead, he sees a few patients with one infection and a few with another.
Thus, even though the total number of infections he treats in any one year
may be quite large, he might never encounter the phenomenon of post-
treatment relapse. This is despite the fact that it occurs with regularity
among some of the many who are treated for any particular infection.
A number of us have been fascinated by this phenomenon for slightly
more than a decade. During that period my co-workers and I have con-
ducted a number of experimental forays into this field without, I must
warn you, penetrating very deeply into an understanding of the phenom-
enon. Indeed, the best it has been possible to do is to skirt the edges, so to
speak. It has been possible to demonstrate: the existence of the phenom-
enon; its wide occurrence among microbial species; its importance to the
clinician and the theorists; and above all, its invulnerability to manipulation
with drugs. It has not been possible, however, to obtain more than frag-
ments of experimental data which might lead to its understanding.
It should also be noted that during the eleven years in which our own
studies of this subject have been in progress, there have been a number of
other groups likewise interested in one or another aspect of the phenom-
enon. I shall make no attempt in this evening's discussion to present a
comprehensive review of all the work which has been done in this broad
field. Instead, what follows is to be regarded as a presentation of the
development of our own thinking in this field and of certain of the experi-
ments which have formed the basis of that thinking.
At the outset it should be noted that recognition that there is a phenom-
enon of microbial persistence was not possible before the introduction of
penicillin. The reason for this is the fact that the early antimicrobial drugs
(quinine, the arsphenamines, atabrine, and the sulfonamides) could never
be administered in very large doses because of drug toxicity. As a conse-
quence, there was no reason to postulate any adaptive plasticity of the
microbes to explain their survival in the tissues despite chemotherapy.
Instead, the survival seemed merely the result of our inability to administer
a sufficient quantity of the drug. With the introduction of penicillin into
syphilotherapy, however, it soon became clear that inadequate drug dosage
was not the principal cause of microbial survival.
Our own interest in this subject originated from experience in the treat-
ment of syphilis. It had long been recognized that syphilis had a remark-
able capacity to become a latent infection. Moreover, the conviction was
widely prevalent that the time antisyphilitic therapy was most effective was
when the early infection was actually producing widespread lesions in the
form of generalized cutaneous disease. Treatment given before that time
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was not quite so effective; treatment given after that time was also less
effective. Indeed, it is not possible to be certain that once true latency has
occurred by natural means, the syphilitic infection is influenced at all by
chemotherapy.
With the introduction, first, of short-term intensive arsenotherapy and,
second, penicillin therapy, it became clear that even the completed treat-
ment of the highly susceptible early (cutaneous) syphilitic infection was
never uniformly successful. Instead, the infection invariably reappeared in
a certain percentage of patients (5 to 15 per cent). Although some of
these "second attacks" of syphilis presumably represented new infections,
some were almost certainly relapses. Moreover, the percentage of incidence
of these second attacks was remarkably constant with arsenical or
penicillin therapy once certain minimal standards of therapy were attained.
Since penicillin, unlike the arsenicals, was effective against other bacteria,
an opportunity was afforded to relate the situation with syphilis to that with
other infections. Several possibly pertinent observations were available.
In 1942, Hobby, Meyer, and Chaffee"1 reported that 99 per cent of the
cells of a culture of hemolytic streptococci were readily killed in vitro by
appropriate concentrations of penicillin, but that the remaining one per cent
were not uniformly eradicated. In 1944, the late Professor Bigger' of
Dublin likewise reported that in certain circumstances it was not possible
to completely sterilize cultures of penicillin-susceptible staphylococci by
prolonged exposure to penicillin. He designated these drug-surviving
microorganisms "persisters" in order to differentiate them from bacteria
which were drug-resistant.
In'1945, in association with Dr. Edith Lincoln, we had been unable to
rid a small group of children of the nasopharyngeal carrier state of type 14
pneumococcus even though the strain was highly susceptible to penicillin.
At Fort Bragg, Rammelkamp and Kirby' found no sustained changes
from penicillin therapy in the pneumococci and streptococci in the pharynx
of so-called "carriers." We were particularly interested at the time in the
fact that certain of the "carriers" in this Fort Bragg study were patients
with the lesions of infectious syphilis. For, despite the fact that the
microbes in the nasopharnyx were not permanently affected, the treponemes
in the inflammatory lesions of the same patients disappeared rapidly under.
the influence of the drug.
Observations of this type viewed together with the peculiar drug-
parasite phenomena in the treatment of syphilis led to the presentation in
1946' of the hypothesis that there was something different about parasites
when they were actually producing disease which made them more drug-
susceptible and that microorganisms which were not drug-resistant in the
usual sense were nonetheless capable of surviving drug therapy in the tis-
sties of man, so that antimicrobial therapy was seldom predictably eradica-
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tive. In short, it was postulated that microorganisms in tissues had an
important degree of adaptive plasticity irrespective of genotype, and that
this plasticity affected their response to drugs.
Attention is thus directed to the state of the parasite. If the most drug-
susceptible state occurs when it is producing active disease, this directs
attention also to the possible role of the inflammatory lesion, a question
INFLUENCE OF DRUGS ON PENICILUN-RESISTANT STAPHYLOCOCCAL POPULATIONS (GIORGIO)
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FIG. 1. Reproduced from Annals of the Newz York Academy of Sciences, 1956, 65,
95.
which will be considered later in this discussion. With introduction
of new antimicrobials, additional examples of the failure of a powerful
drug to be eradicative in a noninflammatory situation have been observed
in clinical practice. The failure of chloramphenicol in typhoid carriers is a
case in point, as is the demonstration by Woodward and Smadel that
chloramphenicol could be given too early in scrub typhus to be completely
effective.
Thus the phenomenon of microbial persistence despite appropriate
chemotherapy appears to have considerable generality. Moreover, it occurs
irrespective of whether the action of a drug, as judged in vitro, is bacterio-
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static or bactericidal. It is important to note further that at least one and
possibly several exceptions exist. Meningococci apparently lack the ca-
pacity to persist in the tissues during chemotherapy, and abolition of the
"carrier state" with respect to these microbes can be easily accomplished
with a sulfonamide. A similar situation probably exists with Shigella
dyseitteriae and the tetracyclines and it may exist with certain antimalarials
deemed capable of eliminating the "tissue" phase of Plasiitodium nwala-riae.
Except for these few instances, however, the phenomenon of microbial
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persistence seems to occur generally among the microbes which produce
infection and disease.
Let us proceed to a demonstration of the phenomenon of microbial per-
sistence in experimental animals. In Figure 1 may be seen the fate of
populations of staphylococci in the kidneys of mice with and without the
introduction of streptomycin therapy. In the untreated animals, the mi-
crobial census rises rapidly until it attains a peak approximating the log
of 10. At this point the census stabilizes, and the population remains
absolutely constant during the remaining 5 or 6 days until the death of the
animal. With the introduction of streptomycin there is no increase in
population in this particular organ. Instead, the population slowly falls,
but even at the end of the experimental period, in this case 28 days,
staphylococci may still be cultured from the kidneys of the animals.
In Figure 2 a similar situation is shown for tubercle bacilli in mice., In
this case the spleen is the organ depicted and, as one may see, the census
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starts at a level of around 106 and slowly rises by more than one logarithmic
unit. After approximately 2 weeks at the higher level, the census slowly
falls to the original level at which it remains stabilized throughout the
experimental period of 118 days. With isoniazid there is an immediate fall
in microbial census which then stabilizes at a level of around log 3 and
remains constant throughout the remainder of the experimental period.
Even at the 118th day it was still possible to culture tubercle bacilli from
the splenic tissue of the animals.
What are the possible explanations for this capacity of the microbes to
persist in the tissues of the mouse in stable census for many weeks despite
presumed exposure to antimicrobial drug? The first thought that comes to
mind is the presence of drug resistance of the genotypic form, but this
possibility can be very easily excluded. In both of the experiments pre-
sented, the culturing of microorganisms in the tissue directly on drug-
containing medium showed plainly that the microbes, or rather their im-
mediate descendants, were not resistant to the antimicrobial drugs which
had been administered.
A second possibility which deserves only brief mention is the factor of
drug-dosage. In similar experiments with isoniazid and tubercle bacilli, for
example, a five-fold increase in dosage to 100 milligrams per kilogram per
day failed to influence the phenomenon in any way." This is to be com-
pared with a dosage of five milligrams per kilogram which will produce a
definite lowering of the microbial population in this experimental system
and indeed will produce very marked changes in tuberculous infections
in man.
A third possibility which is still frequently stated in the literature is that
the drug is confronted by "barriers" in the tissue. These barriers are pre-
sumed to exist in the form of "fibrotic walls" of abscesses, large avascular
areas, or the "walls" of leukocytes or phagocytes.
The factor of fibrous walls was investigated experimentally by Dr.
Robert McCune in our laboratory. Doctor McCune used a technique pre-
viously developed whereby triple-layered agar discs about the size of a
25-cent piece are placed in the peritoneal cavity of rabbits or cats.'7 The
central layer of the disc can be implanted with microorganisms which in
this situation are thus subsisting almost entirely on nutriment provided by
the host. In the particular experiment with which we are concerned the
discs were not seeded with microorganisms. Instead, Dr. McCune studied
the transfer into the center of the disc of a number of commonly used anti-
microbial drugs, for example, penicillin and streptomycin. The drug
transfer was measured both when the discs had been recently implanted,
say, within 12 or 24 hours, and when they had been persisting in the
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peritoneal cavities of the animals for a 28-day period. In the latter situa-
tion, a 2-millimeter, dense, highly organized wall had formed around the
disc. In effect, therefore, each disc represented an area of "dead" tissue, 2.5
centimeters in diameter, surrounded by a living, highly organized, dense
fibrous wall.
Dr. McCune was able to demonstrate quite conclusively that the distribu-
tion of penicillin and streptomycin and other drugs into the center of the
disc occurred rapidly and completely. Moreover, the drug transfer oc-
curred in identical fashion whether the disc had just been implanted in the
peritoneal cavity or whether it was surrounded by the fibrous wall at the
time the host animal received the drug.*
The question of the barrier provided by the boundary of phagocytes was
studied with penicillin and staphylococci by Dr. Ralph Tompsett of the
Department of Medicine in our institution.' He found that appreciably
more staphylococci survived when they were situated within polymorphonu-
clear leucocytes suspended in plasma in vitro than when they were exposed
to the penicillin outside the phagocyte. Nevertheless, it is noteworthy that
even though the staphylococci survived better within the cells than outside
the cells, the populations subsisting inside the cell were reduced by approxi-
mately 90 per cent. In other words, there was a great quantitative differ-
ence in the results with the intracellular and the extracellular staphylococci,
but even the intracellular microbes were influenced by the penicillin to a
very large extent.
At the National Institutes of Health, Dr. Harry Eagle' has shown that
approximately 63 per cent of the penicillin present in an extracellular
environment was transferred into Hela cells and mouse fibroblasts. If it
can be assumed that human phagocytes behave in the same fashion, very
considerable amounts of penicillin should have been present within the
phagocytes in Dr. Tompsett's experiments. Nevertheless, in additional
experiments he introduced the penicillin in much larger doses, namely 100
units per milliliter. Even in this situation, 5 to 10 per cent of the intra-
cellularly situated staphylococci survived. Thus, the quantitative aspects of
the phenomenon were not affected by very considerable increases in the
concentrations of penicillin outside the cells.
It appears, therefore, that the ability of a minority of the staphylococci
to survive when situated intracellularly is not a consequence of failure in
the delivery of penicillin to the interior of the cells. On the contrary, the
* A number of observers have demonstrated in caseous lesions in the tuberculous
lungs of humans that antimicrobial drugs do indeed penetrate necrotic areas. This has
been shown in the case of streptomycin by Canetti' and in the case of isoniazid by Dr.
Barclay and his associates' at the University of Chicago.
263YALE JOURNAL OF BIOLOGY AND MEDICINE
persistence of the microbes within the single cell of the phagocyte would
seem to be a miniature replica of the situation as it obtains in the host as
a whole.
A fourth possibility to explain microbial persistence is that the environ-
ment of the inflammatory lesion exerts an antagonistic influence on the
action of the antimicrobial drug. This has been a popular concept, and I
confess that I have done my share in textbook chapters and similar writings
to present it credibly. However, I no longer believe that it can stand up to
critical scrutiny as a reasonable explanation.
The case for environmental antagonism of drug activity consists of point-
ing out that there is a diffusion gradient through nonliving tissue so that,
depending on the size of a necrotic area and the drug supply at the
periphery, sufficient quantities of drug might not penetrate to the center;
that binding to macromolecular protein complexes might easily result in
deviation of the drug from its appointed task of reaching the parasite; that
changing the environmental pH has a marked effect on the action of certain
antimicrobial drugs; and finally, the fact demonstrated in the microbial
population studies in mice, that both tubercle bacilli and staphylococci
attain considerably higher populations in some organs than in other organs
of the same animal. In the case of staphylococci, the organ of maximal
census is the kidney; in tubercle bacilli, it is the lung.
Examination of these possibilities for a direct environmental antagonism
of drug activity makes it seem unlikely that their role is particularly sig-
nificant. For example, different drugs presumably have different diffusion
gradients through different types of necrotic tissue. But, in the circum-
stances which obtain in the treatment of humans, it is distinctly improbable
that any wide differences materially impede the complete impregnation of
the lesion. It will be recalled from the agar-disc experiments, in which only
short-term therapy was given, that fairly large-sized areas of nonliving
material quickly became full of drug. In the treatment of infections in
humans we are not dealing with a period of 12 or 24 hours but with days or
months. Throughout these long periods there is a constant delivery of a
great excess of antimicrobial drug to the periphery of the necrotic lesion,
and, with such a constant excess at the periphery, the drug concentrations
in the center should be high.
Essentially the same objection holds against the assumption that drug-
effectiveness is seriously impaired by macrocolecular binding. Such pro-
tein-binding is an easily reversible phenomenon, and the degree of binding
depends upon the concentration of drug in the immediate environment.
Hence, even if macromolecular binding were occurring, quantities of drug
would also be being released depending on the surrounding concentration.
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Here again, when dealing with the large excesses of drug given over the
long periods that occur in the treatment of an actual infection, it would
seem that however active macromolecular binding might be, it still could
not possibly "sop up" all the drug with which the lesion is flooded. The
factor of environmental acidity is more subtle and will be discussed in
connection with the next possibility.
The phenomenon of "organ difference,"* namely, that certain parasites
are more susceptible to certain drugs when subsisting in one organ of an
animal than in another organ of the same animal, obviously could represent
environmental antagonism of drug activity. An important objection to this
interpretation stems from the experiments presented previously dealing
with the behavior of populations of staphylococci and of tubercle bacilli in
the tissues of the mouse. For example, in the case of the mouse spleen and
streptomycin we have an organ in which tubercle bacilli actually multiply
during drug therapy at first and never fall below the original census. In
contrast, with staphylococci in the spleen, even in the absence of drug
therapy, the populations fall steadily, and with streptomycin therapy the
populations of staphylococci fall to extremely low levels. Thus we have the
same drug, streptomycin which in effect is highly "active" in the spleen
when it is acting on staphylococci and considerably less "active" in the
spleen when it is acting on tubercle bacilli. This makes it most unlikely
that the antagonism of the streptomycin action represents an influence of
the splenic environment per se on the drug. It is far more credible to infer
that there is something about the respective states of staphylococci and
tubercle bacilli when they are subsisting in the spleen which causes a
difference in their reaction to streptomycin.
In the same way that the same drug in the same organ is highly effective
against one parasite and is considerably less effective against another, one
can see that the same drug may act differently in different environmental
circumstances in sitro. For example, it is well recognized that streptomycin
loses a considerable portion of its effectiveness in partially anaerobic en-
vironments. This can be easily demonstrated for staphylococci and for
tubercle bacilli. Nevertheless, in the very same circumstances, streptomycin
is active on E. coli.u Likewise, pyrazinamide is inactive on tubercle bacilli
of human origin when tested in environments within the physiologic range
* It should be pointed out in passing that there is a human counterpart for this "organ
difference" in that one could say penicillin is an excellent drug for the treatment of
pneumococcal infections of the lung but less effective for the treatment of the same
infection when it has penetrated the pleural cavity or exists in the central nervous sys-
tem. The same holds true with streptomycin and tubercle bacilli, namely, the drug is
highly effective in the lung, less so in the pleural cavity or in the central nervous
system.'
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of pH. Yet, when the same environment is made acid, the pyrazinamide is
highly active on tubercle bacilli of human origin.' This change from
"physiologic" pH to acidity does not cause tubercle bacilli of bovine origin
to become susceptible to pyrazinamide. Thus in two very closely related
tubercle bacilli, so closely related that they almost represent mere strain
variants, a change in environment produces drug susceptibility in the one
but not in the other. This makes it highly likely that the influence of the
acidic environment is on the tubercle bacilli and not on the pyrazinamide.
Now to sum up this question of environmental antagonism of drug
activity. It is easy to show that environmental changes result in changes
in drug effectiveness. By the same token, all of these changes could equally
well represent influence of the environment on the parasite instead of on
the drug. Some of the observed changes, moreover, presumably reflect
influences which could have been exerted only on the parasite. In view of
these considerations, together with the fact that a large excess of drug
should usually be present in the lesion, it appears that environmental antag-
onism of drug activity may well occur, but that seldom, if ever, should it
attain a magnitude that would provide a satisfactory explanation for the
phenomenon of microbial persistence.
Let us turn now to consideration of the possibility that insofar as the
tissue environment affects drug-susceptibility it does so by an influence
exerted primarily on the parasite rather than on the drug. This makes it
necessary to presuppose that the parasite is capable of assuming a state in
which it is neither permanently incapacitated by the drug nor does it
multiply freely in the presence of drug as do the genetically drug-resistant
microbes. In short, the parasite may be said to be "indifferent" to the drug
and I have taken the liberty of designating such a supposed state as "drug-
indifference." Intimately related to this question are the questions of
whether "drug-indifference" may also occur essentially independent of
environmental influences and whether such a state could be actually induced
by the presence of antimicrobial drugs in the tissue environment. As it
seems easier from the standpoint of the discussion to take up first the ques-
tion of the relation of tissue environment to "drug-indifference," considera-
tion of these other two questions will be deferred until later.
We are obviously presupposing that the nature of the environment can
produce detectable changes in the parasite and that some of these affect its
drug-susceptibility. In order to establish these presuppositions, it is neces-
sary to show that a state of microbial "drug-indifference" exists, that it is
reversible, and that it may be induced or specially favored by the particular
nature of the tissue environment.
26
Volume 30, February 1958Microbial persistence MC DERMOTT
It seems to me that highly credible evidence can be adduced in support
of all these presuppositions. Examples exist of the fact that the nature of
the environment can change the form of the parasite. R. G. Wittler' has
observed a considerable morphological change in H. pertussis during its
sojourn in the mouse lung. In more recent experiments, Wittler, Carey,
and Lindberg' have observed the reversion of a pleuro-pneumonia-like
organism (PPLO) to a corynebacterium during residence in Hela cell tis-
sue cultures. Of even greater interest was the fact that the PPLO form
showed little if any cytotoxicity for the cells in which it was situated until
yeast extract (or staphylococcal filtrate) was added to the extracellular
environment. Considerable destruction of tissue ensued, then the PPLO
form was converted to the L-form. The L-form was subsequently con-
verted to the orthodox corynebacterium on further cultivation with the aid
of mucin. These investigators state: "From our observations, it seems
likely that factors which produce changes in host cells may in turn result
in changes in the form or in the type of growth of the infecting organism,
yet this may not always be readily apparent when the organism is again
cultured in vitro."
A particularly dramatic example of this same type of phenomenon was
recently observed by Dr. Dubos in his studies with M. fortuitum.7 This
mycobacterium, like tubercle bacilli and staphylococci, proliferates more
readily in certain organs of the mouse than in other organs. For example,
the peak census of this microbe is attained in the kidney rather than in the
lung. Dr. Dubos has observed that cultures of M. fortuitum assume either
one of two quite distinct forms. In one form the colonies appear as a hard
heaped-up button without a peripheral lacy skirt; in the -other form, the
colonies are flatter and extend for a considerable distance from the central
core forming a peripheral "skirt." The important thing is that the mi-
crobial populations cultivated from one organ of the mouse assume one of
these colonial patterns, whereas when cultivated on the same medium but
from another organ they assume the other colonial pattern. There is every
reason to believe, therefore, that depending upon certain aspects of the
environment in the particular organ, the assumption of one or the other of
these colonial patterns becomes predominant. Thus the environment of the
organ appears to determine the state of this particular parasite. Dr. Dubos
has carried these studies even further and can now demonstrate that a
purified substance known to be present in the tissues, when incorporated
into the medium, can determine which of the forms is assumed by the
parasite.
From these examples chosen-the studies of Wittler and associates and
those of Dubos-it may be seen that the first presupposition that environ-
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mental factors can determine which of several possible different states will
be assumed by a parasite is clearly the case. The presupposition that there
should be a state of "drug indifference" and that it should be reversible can
very easily be demonstrated by a simple experiment with penicillin and
Group A beta streptococci in a favorable medium, maintained first at ice-
box temperature and subsequently at incubator temperature. In the cold
environment the microbial population remains absolutely unchanged, even
though it is afforded a favorable medium and high concentrations of peni-
cillin are present. When this same culture is removed from the cold
environment and put in the warm environment, two things happen at the
same time. The population rapidly increases in the absence of penicillin
and rapidly falls in the presence of penicillin. This simple experiment,
which has been performed with a number of microbial species and a num-
ber of drugs, clearly shows that there is a state of "drug-indifference,"
that it is reversible depending on environmental changes, and that such
states can be induced or favored by the nature of the environment.
Admittedly, the particular environment chosen from the demonstration
cited is a highly artificial one. What is the situation in circumstances more
directly related to the circumstances of an infection? First, let us start
again with the simple system of Group A beta hemolytic streptococci and
penicillin. Virtually all of the published experiments on the dynamics of
the action of penicillin or other drugs in vitro have employed a relatively
standardized system. In this system actively growing microbial popula-
tions with a total census of about 10' are subjected to the action of the
drug, let us say, penicillin. In these circumstances there is a rapid and
essentially straightline fall (on a logarithmic scale) of the microbial popu-
lation to low levels or indeed, in many cases, to zero within a few hours.
It is the fact that this does not happen in the animal body that represents
the phenomenon of microbial persistence. But why has there been this
disparity between the events in the test tube and what happens in the body?
In some unpublished experiments in our laboratory conducted by Dr.
Carl Berntsen it was noted that this rapid fall in microbial population
under penicillin did not occur when the initial populations of streptococci
were high, say around 108 or 109. In the latter circumstances an im-
pressive portion of the population of supposedly penicillin-susceptible
streptococci was nevertheless capable of withstanding the action of peni-
cillin for a week or longer. The census slowly fell, but even at the end of
the week appreciable numbers of streptococci could be cultured from the
medium. In short, penicillin acted dramatically on small microbial popula-
tions of the order of 106, but its effectiveness was reduced to a very great
extent on larger populations of the order of 108 or 10'.
268
Volume 30, February 1958Microbial persistence I MC DERMOTT
The question immediately arose as to how great are the microbial popu-
lations in the lesion of an infection? Dr. Berntsen made a number of
studies of this point using vegetations from heart valves of untreated pa-
tients dying of bacterial endocarditis (medical examiner's cases), freshly
excised tonsillar tissue handled with techniques designed to prevent mi-
crobial proliferation of the microbe after excision, and vegetations from
experimentally produced endocarditis in rabbits. In addition, there was in
progress in the laboratory at the same time a large number of quantitative
studies with the microbial enumeration technique of the infections produced
in mice by tubercle bacilli and staphylococci.
All of these observations tended to show the same thing, namely, that in
the mouse organ or tissue with the greatest microbial census (or in the
other tissues of man mentioned), the value for the microbial population
almost always ranged between 10' or 10' per milliliter of emulsified tissue.
A minor exception to this is the fact that in some circumstances in the lung
the peak census of tubercle bacilli ranges between 107 and 10'. It is of
considerable interest that these values of 10' and 10' for the peak census of
these various microbes are essentially the same as are attained by these
three microbial species when they are allowed to grow under favorable
conditions in the test tube. Thus with staphylococci, beta hemolytic strep-
tococci, and tubercle bacilli, both in the test tube and in the organ of the
mouse in which the highest population occurs, the peak value is essentially
the same, namely, 10' or 109.
Populations of penicillin-susceptible streptococci or penicillin-susceptible
staphylococci of this size, 10' or 10', are not very markedly influenced
in vitro by the introduction of penicillin. In short, in vitro at least, they are
"drug indifferent"; they are not "drug resistant." Moreover, in the animal,
populations of this size of either streptococci, staphylococci, or tubercle
bacilli are considerably less affected by isoniazid or penicillin than popula-
tions around 10' in the same animal.
We have, therefore, to ask ourselves the question: in what ways other
than in size do these large "drug-indifferent" microbial populations differ
from the smaller drug-susceptible populations?
With the large populations the microorganisms have been growing in
the environment for a longer period in order to attain the high census.
This means two things: the large population is an older one, and it has
been reacting with its environment for a longer period than is the case with
the small populations. Thus there has been a greater opportunity for chem-
ical modification of the environment, either in the culture medium in vitro
or in the inflammatory lesion in the animals.
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In a further series of unpublished experiments by Dr. Carl Berntsen it
was shown that when age of the population and the environmental altera-
tions produced by growth are divorced experimentally, large populations of
streptococci are as susceptible to penicillin as are small populations. In
these experiments, large (108 and 10'), populations of Group A beta
hemolytic streptococci were employed in which the majority of the microbes
were less than 4 hours old. Such high populations of very young organ-
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FIG. 3. Reproduced from the British Journal of Experimtental Pathology, 1957, 38,
419.
isms were obtained by cultivating the streptococci on a large scale and
resuspending them in an appropriate volume of fresh medium. It was
possible to demonstrate that when the majority of the cells in such a large
population were less than 4 hours old, the population was just as suscepti-
ble to penicillin as when the young cells were initially present as a
small population. It was also possible to show that this penicillin-suscepti-
bility of the large 4-hour-old populations obtained to the same extent when
the populations were implanted in the mouse muscle as when they were
inoculated into a test tube. Thus it may be seen that not only were these
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large drug-susceptible populations quite young, but in both the mouse and
in the test tube they were being tested in an environment which they had
had no previous chance to alter.
If the relative insusceptibility to penicillin of the large "naturally" grown
populations of streptococci were reversible by changing the environment,
it would constitute evidence that the "drug-indifference" of the microbes
represented an adaptive state to certain environments. Indeed, one aspect
of the factor of aging of the population itself conceivably could be altered
by environmental changes and regarded as an adaptation, for the propor-
tion of young microbial cells to old cells, i.e., the capacity of the population
to form new cells, might vary with the environment.
A related aspect of this question of reversibility of the "drug-indiffer-
ence" of large populations is the fact that if the peak census attained in the
mouse tissues or in the test tube wlere not the maximtal attainable census
in these situations, it follows that what we designate as the peak census in
actuality represents a microbial population under some inhibitory influence.
In both the mouse and the test tube it can be shown that this is the case,
and that the peak census obtained by the microbes is not the maximal
obtainable census if the circumstances are modified.
In the mouse, this can be demonstrated by the administration of cortisone
to animals infected with tubercle bacilli, as may be seen in Figure 3. The
lowest curve in the figure shows the population of tubercle bacilli in the
mouse lung attaining a peak between 107 and 108 and then stabilizing at
essentially that census thereafter. In the animals maintained on hydro-
cortisone, however, the microbial census was as high as 10's, yet the animals
were able to survive at least for a period of a week or so in these circum-
stances.* In the test tube with staphylococci and penicillin, Dr. David
Rogers'm of our Department of Medicine has shown that a microbial popu-
lation which has become stable at a census of 108 will increase to 10' simply
by the process of shaking which, of course, also involves aeration.
These two sets of observations are interpreted as showing that the
environment constituted by the tissue or the test tube in which microbial
populations have grown to 10' is exerting an inhibitory influence at that
point, for if the cessation of population increase were determined by factors
within the parasite and independent of the environment, it should not be
regularly influenced by environmental change. Coincidental with this
inhibitory influence of the environment on the microbes is their relative
indifference to the drugs.
* It should be noted that there is a definite tendency toward stabilization even of
these very large microbial populations developing in hormone-influenced animals.
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It can easily be shown in the test tube that the inhibitory influence which
causes the growing populations to stabilize is not a question of the exhaus-
tion of nutriment from the medium. In Dr. Berntsen's experiments fresh
daily inocula of streptococci were repeatedly allowed to grow day after day
to the point of stabilization in the same medium from which the bacteria
were removed by filtering at the end of each 24-hour period. After 8 or 10
days, the fresh inocula of streptococci in this same medium would still grow
logarithmically up to the same peak census and then stabilize. Thus nutri-
ment, in the sense of something generally available through the medium,
was not exhausted under these conditions. Likewise, to some extent, the
experimental results stand against the concept that toxic substances pro-
duced by the microbes are responsible for the cessation of population in-
crease. Certainly the possibility is excluded that a filter-passing substance
was present in sufficient quantity to exert an influence throughout the
medium as a whole. The possibility remains, however, that minute concen-
trations of inhibitory substances might be elaborated in the immediate
environment of the bacteria or might adhere to the filter. Thus, it appears
that there is some factor or factors associated with attainment of the
"crowded" state by the microbes which exerts an inhibitory influence on
further population growth. This factor may be something intimately asso-
ciated with the immediate environment of the microbe but does not seem
to be something which is detectable throughout the environment as a whole.
To recapitulate, it can be shown that a population of microbes growing
either in the tissues or in the test tube becomes subject to some inhibitory
influence before it reaches the maximal attainable population in those cir-
cumstances. And, at the time that the population becomes subject to the
inhibitory stabilizing influence, the microbes also become "drug indifferent."
The important thing from the standpoint of the argument is the fact that
when this environment which has now become inhibitory is altered, not
only do the populations show themselves capable of further growth, but
they also once again become drug susceptible. A small aliquot of the large
"drug indifferent" microbial population is quite susceptible to penicillin
when tested separately in fresh medium. Moreover, Dr. Rogers has clearly
shown with the penicillin-staphylococcus system in sitro that penicillin-
susceptibility reappears coincidentally with the new population upsurge
produced by shaking and aeration.
It appears, therefore, that it is not the age of the population per se, but
its adaptive changes to the environment it has altered while attaining that
age which are associated with its "drug-indifference." These environmental
relationships (i.e., the consequences of crowding) are responsible for the
failure of the population to continue to increase in the test tube and con-
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ceivably are responsible in part for the failure to continue to increase in the
tissues. In terms of the population as a whole, age is a factor, but it is a
factor which remains responsive to environmental change. When the
environment is altered so that the same "old" cells begin to divide into a
greater number of freshly born "new" ones (to the extent this occurs), the
age of the population has been made more youthful.*
In considering this question of "age," it is intriguing to note that if
microbes possessed the capacity to be susceptible to penicillin or isoniazid
only when they were quite young, e.g. less than four hours old, certain of
the experimental observations presented above or subsequently would be
satisfactorily explained.
At first glance, this explanation appears to be identical with the familiar
one that "penicillin acts only on multiplying bacteria." In crude terms the
two explanations are indeed the same; nevertheless, a subtle difference does
exist between them. With the familiar explanation it is implicit that micro-
bial cells in the metabolic state which leads directly to cell division are ipso
facto in a state in which they can be "killed" by penicillin in the environ-
ment. At any time a so-called "resting cell" enters into this pre-divisional
state it is drug-susceptible. With the presently proposed explanation,
multiplication or cell division is only a side aspect of the issue. Instead, it
is postulated that as young microbes grow, they lose something or gain
something which makes them resistant to drugs.** In other words, an
adaptive mechanism becomes activated, and the capacity thus developed
might well remain irreversible in terms of the individual cell. When the
environment is suitably altered so that more of these "old-adapted" cells
give birth to young "unadapted" cells-to the extent this occurs-the
population becomes drug-susceptible.
In short, the environment tends to antagonize drug-effectiveness by be-
coming unfavorable for the birth of drug-susceptible microbes.
Let us turn to consideration of that other aspect of the aging of a
parasite-host interaction, namely, the inflammatory changes produced in
the environment. Dr. Harry Eagle8 has studied the influence of penicillin
on Group A beta hemolytic streptococci which have been introduced into
the gastrocnemius muscle of the intact mouse. He was able to show that
when the administration of penicillin was withheld for 18 or 24 hours after
the start of the infection, it had far less of a population-reducing effect than
* The concept that bacterial cultures exhibit a period of "physiological youth" with
changes in morphology and behavior resembling what occurs in more highly differen-
tiated multicellular organisms has been suggested by several writers (e.g. Sherman and
Albus, 1924) and is presented on page 143 of The Bacterial Cell by R. J. Dubos
(Harvard University Press, 1945).
**Recent work (see Park and Strominger'; Lederberge4) suggests that penicillin
interferes with the synthesis of the cell wall of young microbial cells and that this does
not occur in fully developed cells.
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when the drug was administered within a few hours. This observation has
been repeatedly confirmed in a number of laboratories including our own.
It gives rise at once to the question under present consideration, namely,
did the inflammatory environment in the older infection exert its influence
on the drug or on the parasite?
There are two sets of observations which indicate strongly that the
effect of the environment was mediated directly on the parasite and that
there were no important environmental effects on the drug. In recent
experiments in our laboratory by Drs. McCune and Dineen it was found
that when staphylococci (Wolbach strain) have been subsisting in the
mouse kidney for 54 hours before penicillin was started, the drug was just as
effective in terms of population reduction as when started at the beginning
of the infection. (It should be recalled that the kidney of the mouse is the
organ in which the most abundant growth of staphylococci occurs, and at
54 hours the populations are at their highest and microscopic abscesses are
apparent although no grossly purulent lesions are yet present.)
The difference in penicillin effectiveness in the Eagle experiments and
those just cited is more credibly attributable to differences between strepto-
cocci and staphylococci in the two sets of circumstances, rather than to
environmental effects on the drug.
The second set of observations on this point was made by Dr. Berntsen
who produced a sterile purulent-necrotic lesion in the gastrocnemius
muscle of the mouse. In control experiments it was demonstrated that this
sterile lesion would support the growth of beta hemolytic streptococci to
the same extent as occurred in unaltered muscle. When the large popula-
tions, i.e., 10' of streptococci, most of which were less than four hours old,
were introduced into this purulent lesion and the animals were treated with
penicillin, there was a rapid fall in microbial census. Indeed, the population-
reducing effect of the penicillin in these purulent lesions was exactly the
same as it was in vitro. When the large "older" populations were intro-
duced, the results were quite different, and the administration of penicillin
had only a slow and imperfect effect on the reduction of the microbial
census. Thus once again when the state of the parasite was one known to
be associated with a high degree of drug susceptibility, the presence of
large purulent lesions had no influence on the full penicillin action.
In this same experimental system, populations of streptococci were stud-
ied which had been grown in vitro for 36 hours. The populations had stabi-
lized under these circumstances and hence were under whatever inhibitory
factors make for such stabilization in vitro. When these populations were
placed in the purulent-necrotic lesion, they were relatively indifferent to the
action of the penicillin. Thus, the change from the in vitro environment in
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which stabilization had occurred to the purulent environment in vivo did
not have the effect of shaking or aeration or cortisone. Instead, the stabi-
lized populations simply maintained their state of relative drug indifference
in the necrotic-purulent environment.
Another example of this sort has to do with staphylococci, penicillin, and
leukocytes. It will be recalled that Dr. Tompsett, using this system, was
able to show that about 10 per cent of the population of staphylococci sur-
vived penicillin when they were inside leukocytes, whereas only .0001 per
cent survived when they were outside the leukocytes. This could represent
either failure of delivery of drug to all of the intracellular staphylococci or
the possibility that the environment provided by the leukocyte induced or
favored the assumption of a state of drug indifference by some of the
staphylococci.
In subsequent experiments Dr. Tompsett' used disrupted leukocytes in
the same numbers as the intact leukocytes used previously. He observed
that the same 10 per cent penicillin survival which occurred when the
staphylococci were situated in the leukocyte likewise occurred when dis-
rupted leukocytes were used instead of intact cells. As he pointed out, the
demonstration of the same phenomenon occurring in the two sets of cir-
cumstances does not establish the fact that the mechanism is necessarily the
same in both instances. Nevertheless, the results are suggestive in them-
selves and have the additional implication that purulent material -per se
may represent one of the environments in which microbes assume a state
of relative drug indifference.
The last-named point was investigated by Dr. W. Barry Wood" in some
experiments published last year. He observed that pneumococci inoculated
into purulent material did not show a rapid increase in numbers, but instead
persisted at the initial census or gradually fell in numbers with the passage
of time. Moreover, Canetti' and others have shown that the caseous lesion
of tuberculosis, when its bronchial communication is not patent, i.e. a
"closed" lesion, has a considerable self-sterilizing capacity.
It can easily be shown that the presence of one antimicrobial drug in the
environment of a microbial population can influence the susceptibility of the
population to another drug. This was originally demonstrated for sulfon-
amide and penicillin by Hobby and her associates and has been the subject
of a series of detailed investigations with a large number of drugs by Dr.
Ernest Jawetz.' Moreover, in studies with antituberculous drugs in our
laboratory," it has been possible to show that the population-reducing
effects of isoniazid during the early weeks of its administration could be
largely neutralized by the concurrent administration of nicotinamide or its
derivative pyrazinamide. Nicotinamide is a weak antituberculous drug,
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whereas pyrazinamide is a relatively strong one. It was further shown that
tubercle bacilli of human origin exposed in 7vvo to isoniazid (or other anti-
tuberculous drugs) had greatly increased susceptibility to the pyrazinamide.
The increased susceptibility to pyrazinamide could also be shown when the
isoniazid exposure preceded rather than accompanied the exposure to
pyrazinamide. Dr. Koch-Weser' and his associates have shown that
sequential exposure of tubercle bacilli to another pair of antituberculous
drugs may affect tubercle bacilli in vitro in a manner distinctly different
from what happens when the bacilli are exposed to both drugs at the same
time.
These examples are cited merely to show that a commonly encountered
component of the inflammatory environment, an antimicrobial drug, can
exert widely divergent influences on the susceptibility of a microbial popu-
lation to other antimicrobial drugs. None of these drug-pairings have so
far proved to be eradicative, and when the influence of the drug-altered
environment happens to be in the opposite direction, namely, toward a
lessening of microbial susceptibility, the phenomenon of microbial persist-
ence is thereby favored. Thus the situation appears to be no different with
respect to environmental influences in general and environmental influences
consisting largely of another antimicrobial drug.
Because the present discussion is primarily concerned with microbial
persistence, attention has been focussed on environmental influences and
microbial adaptations of a sort that would tend to lessen the susceptibility
of a microbial susceptibility to certain drugs. In the case of tubercle bacilli,
a population which has subsisted in the mouse for 21 days is more sus-
ceptible to pyrazinamide, and probably also to streptomycin, than a popu-
lation freshly introduced into the animal. It will be recalled that the
susceptibility of tubercle bacilli of human origin to either of these drugs
in vitro can be drastically modified by appropriate manipulation of the
environment. Moreover, a particular environmental change will modify the
pyrazinamide-susceptibility of tubercle bacilli of human origin, whereas it
will not affect those of bovine origin. Or a particular change will modify
the streptomycin-susceptibility of tubercle bacilli, but not of E. coli. As in
the case of environmental lessening of drug-susceptibility, the change seems
to depend on the adaptive plasticity of the microbe and not on the presence
of an environment more favorable for drug "activity."
To sum up this portion of the discussion: it is believed that microbial
persistence is the result of the ability of microbial populations to assume a
state in which they are relatively insusceptible to an antimicrobial drug. It
is believed that the assumption of this state, which is called "drug-indiffer-
ence,?" is induced or favored by the influence of the environment on the
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microbe. Included in these "environmental influences" are antimicrobial
drugs and intermicrobial relationships* as well as the influences of the host
cellular and humoral defense reactions and the reactions of inflammation.
An environmental change of a particular sort may make the same para-
site display widely different behavior to different drugs or may make
different parasites display less than their maximal susceptibility to the
same drug. For these reasons it is believed that it is the adaptive plasticity
of the microbe which is the important factor in the influence of environment
on drug effectiveness and not a physical or chemical antagonism. exerted
directly by the entironment on the drug.
The environmental factors which can influence microbial populations
toward lessened or enhanced susceptibility to drugs include the orthodox
host-immune mechanisms, such as phagocytes and antibody, and the pre-
vious or concurrent presence of another drug. Probably of even greater
importance are forces as yet undefined but nonetheless visible in the formn
of effects, among them those, neutralized by steroid hormones, which pre-
vent the microbial populations from rising in certain organs to the peak
attained in other organs of the same animal; the consequences of tissue
alteration, i.e. inflammation and necrosis; and the consequences of mi-
crobial crowding or "the territoriality phenomenon" which can be demon-
strated in Titro and can be reversed by environmental manipulation.
Although instances of drug-enhancement from environmental adaptation
of the microbes occur, thus far they have not been observed to lead to total
eradication of a microbial population. Consequently, the net over-all effect
of the various environmental influences on drug effectiveness is in the
direction of providing situations which favor microbial persistence.
The question arises as to the relation of microbial persistence to the pro-
duction of tissue changes and the calling forth of immune mechanisms.
There is some reason to believe that stabilization of a microbial population
per se, as may happen, for example, at a high census in an untreated infec-
tion, does not necessarily coincide with a cessation of progressive changes
in the tissues. With respect to "persisters," however, we are considering a
population which is present at a very low census. The possibility cannot
be excluded that such small numbers of apparently "inactivated" microbes
do not give rise to tissue reactions. It can be said, however, that if such
changes occur, they are subtle in nature, for the characteristic tissue
* With respect to the purely intermicrobial aspects of this situation, the concept is, of.
course, a broadening of the concept of the viral "interference phenomenon" and the
application to microbes of the biological concept of "territoriality" as it applies to
animals of the same and different species (see The prevalence of people by Marston
Bates').
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changes produced by tubercle bacilli or staphylococci are not seen in the
animals harboring "drug-persisters." With respect to persisters and the
evocation of immune mechanisms, it can be said, as will be discussed below,
that in certain circumstances at least, microbial persistence can occur with-
out evoking the host-immune response characteristic of that particular
infection.
Reflection on the question of the relation of persisters to tissue changes
or immunity leads naturally to speculation concerning the form in which
microbial persisters exist during their periods of hibernation. Until quite
recently there was no convincing demonstration of a correlation between a
particular microbial morphology and a physiological state of drug-indiffer-
ence. One had to be content with analogies drawn from the phenomenon
of bacterial sporulation' or advance the dead-end argument that non-
visible, drug-indifferent forms existed for microbial species not known to
have multiform life cycles. Within the past few years, however, there have
been a number of studies dealing with the L-forms or protoplasts of certain
microbes that appear to have a definite bearing on the action of penicillin.
Before considering these recent penicillin studies, it should be noted
that Schnitzner and his associates' observed the occurrence of small colony
variants, the so-called gonidial or G-forms, in cultures of staphylococci
exposed to penicillin. Wise and Spink have made an extensive study of
this subject.' In their studies with staphylococci the colonies were so
minute as to be barely visible macroscopically and the microbes appeared
to be unaffected, or at least they survived, concentrations of penicillin which
were usually inhibitory. On subsequent cultivation in the absence of peni-
cillin, the minute colonial forms gave rise to staphylococci of orthodox
colonial morphology and in this state the microbes were susceptible to
penicillin. Moreover, they found evidence of the presence (but not the
reversion) of these G-forms in zvvo. A somewhat similar type of demon-
stration was made by C. H. Lack' with tubercle bacilli. Using phase
contrast microscopy and a hot box, he observed that tubercle bacilli sub-
jected to starvation or antimicrobial drugs (streptomycin, PAS, penicillin,
isoniazid) became progressively smaller until the cells were coccal rather
than bacillary. When nutrition was restored, some of the coccal forms grew
back to bacillary forms. Although Lack believed that these coccal forms
probably represented a stage associated with drug survival, he did not
consider the point as having been established.
The results of these various studies suggested the existence of morpho-
logic counterparts to certain physiologic states involved in drug suscepti-
bility, yet none were presented as constituting clean cut evidence on that
point. Within the past year, however, several studies have been reported
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dealing with the L-forms or protoplasts of bacteria which seem to have a
definite bearing on the subject.
When the cell wall of a bacterial cell is lysed under appropriate condi-
tions, the bacterial cytoplasm and its limiting membrane may continue to
exist as the so-called protoplast (Weibull'). This process is regarded by
several groups of investigators (Hahn and Ciak,'0 Park and Strominger,tm
Lederberg," Pease') as being identical with what happens in the first stage
of the formation of the L-form from the normal vegetative form of certain
bacteria. The protoplast is quite fragile and is especially responsive to the
osmolarity of the environment. Nevertheless, protoplasts can survive in
vitro with appropriate manipulations of the environment and if protoplasts
and L-forms are identical microbial forms, protoplasts obviously survive
in vivo, where the osmotic homeostatis might be expected to be more pro-
tective. The environmentally induced conversion of L-forms to a vegetative
corynebacterium in Hela cells and a similar type of change with H. pertussis
in the mouse lung by Wittler and her associates have been previously
mentioned.
The importance of these studies of protoplasts with respect to microbial
persistence lies in the fact that several investigators have shown (Leder-
berg,'6 Liebermeister and Kellenberger," Hahn and Ciak,'0 Pease') with
two microbial species (E. coli; Proteus vulgaris) that protoplasts can be
regularly induced by appropriate exposure to penicillin. Mforeover, the
protoplasts so induced are not destroyed by penicillin and when the peni-
cillin is remtoved fromn the environment, the protoplasts revert to the vegeta-
tive (and penicillin-susceptible) form of the microbe. In addition to these
two microbial species in which penicillin-induced protoplast formation has
been shown, Park and Strominger have presented highly suggestive evi-
dence with staphylococci that it is the synthesis of the bacterial cell wall
which is interfered with by penicillin.
Tlhus there now exist experimentally demonstrated biological precedents
for every step of the argument that microbes possess an adaptive plasticity
in relation to their environment which permits them to persist in the animal
body despite exposure to the appropriate antimicrobial drug.
It is important to realize that what has been demonstrated has to do with
precedents or examples and not with the actual nmechanics of the phenom-
enon of microbial persistence per se. Protoplast induction has been demon-
strated only for penicillin (of the commonly used antimicrobial drugs) and
only for two microbial species, neither of which produces what is conven-
tionally regarded as a penicillin-susceptible infection in man. At the
moment, therefore, protoplast formation might well be regarded more as an
explanation of why penicillin fails to be effective in certain Gram-negative
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bacillary infections rather than why it fails to eradicate the Gram-positive
microbes from animal tissues. Nevertheless, these recent studies clearly
show the existence of a drug-induced microbial morphology which is
correlated with the physiological state of "drug-indifference" and both the
morphological expression and the physiological state are reversible by
appropriate manipulation of the environment of the microbes.
In the "persisting" states which have just been conjectured, the microbes
are not only physiologically unreceptive to the drug, but have been morpho-
logically altered as well. There is some reason to suspect that this concept
represents too crude an oversimplification of what actually happens, or at
least that it represents only one type of a phenomenon which may occur in
several forms. The principal reason for this suspicion is the fact that, in
certain circumstances, microbes which are genetically resistant to a par-
ticular drug may nevertheless "persist" in animals treated with that drug
without showing any tendency to increase in numbers. If microbial per-
sistence were entirely dependent on a morphological change in the microbe,
for example, protoplast formation with the loss of the cell wall, it is difficult
to visualize how this could occur if the individual microbial cell were
genetically resistant to the drug in question.
When a strain of tubercle bacilli or staphylococci that will grow freely
in the presence of a particular drug in vitro is injected into a mouse and the
corresponding drug is administered, the microbial population in the mouse
will increase in essentially the same way as in untreated animals. The
microbes cultured from the tissues at any time during the course of therapy,
will show the same drug-resistance in vitro (considering the strain as a
whole) as was the case with the pre-inoculation strain. In contrast, as we
all know, when the infecting strain is drug-susceptible and the drug is
administered, the initially high census of culturable microbial cells falls to
a greater or lesser degree and persists apparently unchanged thereafter.
The persisting cells (or rather their descendants) are almost invariably
drug-susceptible when subsequently tested in vitro; when drug-resistant
variants emerge, the microbial population usually shows a rapid upsurge
despite the chemotherapy.
The point for consideration, however, is the fact that this upsurge of a
small drug-resistant population does not invariably occur. Sometimes,
with both tubercle bacilli and staphylococci, these drug-resistant microbes
just persist, showing no tendency to increase in census. Whether the con-
tinued administration of the drug is a factor in this situation, despite the
drug-resistance of the persisting strain, cannot be stated from our own
studies because thus far we have not made observations on such popula-
tions after the cessation of therapy.
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At the semantic level, if not otherwise, it is difficult to visualize exactly
how genetically drug-resistant cells would have the opportunity to assume
physiological states of "drug-indifference." This suggests, therefore, that
there are aspects and implications of the physiological states of drug-
indifference which have nothing to do with the drugs. This is to say that
the microbe is capable of assuming states in which it is sufficiently in bal-
ance with its host environment so that it neither proliferates nor is de-
stroyed and can persist in such states for long periods. Obviously, this is
but another way of saying something we all know, namely, that microbial
infections (including the drug-resistant cells therein) can become dormant
or truly latent in an animal host by natural processes and hot only as a
consequence of antimicrobial therapy. In short, it is probable that the
mechanisms of microbial persistence despite drug therapy are very much
like the mechanisms which permit infections to become dormant or latent
in the absence of therapy.
It is not the purpose of the present discussion to consider the host
mechanisms possibly operative in maintaining an infection in the dormant
or truly latent state.* Obviously, both the known and probably certain as
yet unknown host reactions play a most important role in this process. The
point for emphasis in the present discussion is that perhaps we have tended
to be too one-sided in our appraisal of this situation and, in quite properly
focusing attention on the host, we have neglected the possible adaptive
plasticity of the parasite. I am thus suggesting that there has been a ten-
dency to regard the parasite in a dormant or latent infection as being very
much like the same parasite when it is actively producing disease, and
hence to regard the difference between the latent and active stages of a
particular infection as depending almost entirely on the momentary status
of the bodily defenses. It is not so much that this viewpoint might be
untrue as that it is almost certainly only one part of a larger picture.
To be sure, in many instances, a change in the tissue environment pro-
vided by the host for the microbe will result in an evocation of an infection
previously dormant. The observations of the Danish medical students
imprisoned in the German concentration camps during the latter days of
World War II represent a case in point.' The diseases that appeared were
all produced by microbial species almost certainly a part of the personal
flora of those afflicted. The extremes of the deprivation of the host were
* In this discussion, the word dormant is used for infections persisting at a low but
detectable level. The word latent is reserved for situations in which the presence of the
infection cannot be demonstrated by any of the available methods and the fact that it
is present can only be detected in retrospect by the appearance of relapse.
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such that the tissue environment of the microbes was almost certainly
altered substantially. Hence, there is no particular reason to assume that
any more marked changes occurred in the microbe than regularly occur in
the change from a "resting cell" to one in the stage of logarithmic growth..
But there are instances, in which the situation is less clear, for example,
Brill-Zinsser disease or latent syphilis. Within a relatively short period
(probably two years) after a syphilitic infection is first established, it be-
comes latent in the majority of those infected. By this is meant that the
presence of the infection can be detected by serological tests, but there is no
way of demonstrating where the infection is persisting in the living patient
nor indeed on post-mortem examination of those dead from other causes.
Once this state of latency is established, it is highly unlikely that spirochete-
mia ever occurs thereafter. It should be noted, moreover, that the major late
complications of syphilis, cardiovascular or neurosyphilis, almost certainly
do not represent evocations of latent syphilis with invasion of new areas,
but rather the emergence to clinical recognition of disease processes which
have been slowly progressive ever since the initial infection. Indeed, the
only evidence that the syphilitic infection is still present in the stage of
latency are the facts that the tissues react to re-inoculation in a markedly
altered fashion and in a small number of those infected cutaneous or
skeletal gummata eventually develop.
It is of considerable interest, in this connection, that despite the many
decades of observation of persons infected with syphilis and subjected to
severe privations, such as occurred in a concentration camp, no one has
ever reported anything remotely resembling the evocation of latent syphilis.
When the latent infection is evoked, as it is in the formation of exterior
gummas, the lesions almost invariably occur at a site of continued trauma.
Since the stage of spirochetemia in such cases was presumably over two or
three decades previously, it is reasonable to assume that T. palliduml must
have been implanted many years before in the area of skin or bone which
gives rise to the gumma. Because of the peculiar predeliction of such
lesions for the sites of continued trauma, however, one must either attrib-
ute an unusual prescience to T. pallidum, or assume that the initial invasion
of these tissues by the spirochete, and its continued- presence thereafter, is
something which occurs on quite a widespread basis. If this is so, it is all
the more remarkable that no amount of deprivation of the host as a whole
appears to do what is apparently done by the continued trauma to a part.
These observations suggest to me that T. pallidum is widely distributed
throughout the tissues initially and exists thereafter in a form quite differ-
ent from the one we have learned to recognize. The fact that T. pallidum
can be demonstrated to be present in the aortic and neural lesions, but not
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usually in gummas, is in keeping with this view. With full recognition of
the highly speculative nature of these "reflections on syphilis," it does
seem as if evocation from the latent state by a particular microbial species
might require some rather considerable adaptive changes on the part of the
parasite and not just merely a breakdown of some control mechanisms of
the host. Indeed, it is not too inconceivable to suggest that the difference
between a dormant infection such as a tuberculous pulmonary lesion and a
truly latent one such as syphilis, might rest right at this very point, namely,
that for evocation the dormant infection requires only alterations in the
host, whereas the latent infection requires changes in the parasite itself.
It is possibly relevant in this connection that a truly latent bacterial infec-
tion in rats and mice which can be evoked by cortisone" is produced by
one species of the genus Corynebacterium, another member of which has
been recently shown to progress through a complicated life cycle in mam-
malian tissue.'
So much for this highly speculative consideration of microbial states
during latency. A question far more germane to the present discussion is
whether the continued administration of an antimicrobial drug exerts any
influence at all in the direction of maintaining an infection in the dormant
or latent state. In other words, are microbes that are not producing
disease, actually drug-susceptible? As most of the information bearing on
this point also has to do with the question of whether microbial persistence
just "happens" or is actively induced by drugs, these two questions will be
considered together.
There is some reason to believe that when a microbial population first
infects a new host, some members of the population are in (or quickly
assume) a state of "drug-indifference" and can be kept in that state for so
long as appropriate antimicrobial therapy is administered. The evidence on
this point consists of a series of clinical observations; indeed the earlier
observations are the ones which originally provoked our interest in the
subject of microbial persistence. In essence, the observations are of two
sorts: recognition of our customary inability to render humans predictably
and uniformly free from the carrier state of otherwise drug-susceptible
microbes, and recognition that microbial persistence usually occurs when
infections are treated immediately after their inception.
The question of carrier states has been considered earlier in this dis-
cussion as was the observation in syphilis that if therapy were started very
early, the results in all the large series of treated patients were never quite
so good as when treatment had been started after clinical evidences of
generalized infection had become apparent in the so-called secondary stage
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of syphilis. In the pre-penicillin days, these differences in therapeutic
results were never marked but they were consistent and appeared to be
definite. Many an experienced syphilologist would tell one privately that
if he acquired syphilis he would attempt to keep that fact a secret until the
infection had progressed to the secondary phase with a generalized cutane-
ous infection, before he would permit the start of arsphenamine therapy.
In short, a drug which was effective when the infection had progressed to
a certain point was somewhat less effective when started prior to that point.
A similar phenomenon has been observed in the chemotherapy of four
other infectious diseases: malaria, scrub typhus, Q-fever, and tuberculosis.
In the first three infections, there is evidence that antimicrobial therapy
exerts its maximal influence only after the infection has evolved to a certain
point-with an apparently static microbial persistence occurring if treat-
ment is started earlier. With tuberculosis, the evolution to a more satis-
factory stage from the standpoint of chemotherapy has not yet been shown
but the apparently static stage of microbial persistence following very early
chemotherapy has been observed.
The evidence from malaria consists of the observation of Coggeshall'
and his associates that the post-treatment relapse rate in tertian malaria
was appreciably less when chemotherapy was started after the patient had
had several individual paroxysms than when the same chemotherapy in the
same time-dose relationships was started after the initial paroxysm of the
disease. The observations in tuberculosis were made by Lelong and his
associates'7 in Paris. They had the opportunity of starting isoniazid therapy
in four infants born of mothers with pulmonary tuberculosis in an infectious
stage. The antimicrobial therapy was started shortly after birth and the
infants were immediately removed from contact with their mothers or
other tuberculous persons and maintained in a protected environment.
At the start of isoniazid treatment, the infants showed no evidence of
tuberculous infection and their cutaneous reactions to tuberculin were
negative. The isoniazid was administered daily for a 3- to 4-month
period during which the infants developed normally and continued to
remain nonreactors to tuberculin. Within four to six weeks of cessation of
the isoniazid, however, and without any known renewed exposure to
tuberculosis, all four infants developed positive cutaneous reactions to
tuberculosis. It appears, therefore, that the isoniazid was able to hold this
very early tuberculous infection suppressed at a level so low that cutaneous
sensitivity to tuberculin failed to develop. Yet even in what might be con-
sidered a most advantageous situation from the standpoint of drug effective-
ness, the isoniazid was unable to eliminate the infection.
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The observations in the rickettsial infections, scrub typhus and Q-fever
are the most clean-cut as they were made in the form of actual experiments
with the use of human volunteers.
In Malaya, Drs. Smadel, Woodward, and their associates showed that
the initiation of chloramphenicol within a matter of hours after heavy
exposure of volunteers to the rickettsia of scrub typhus prevented any
clinical manifestations of illness so long as the chloramphenicol administra-
tions were continued. Once the drug therapy was discontinued, however,
even after so long a treatment period as 40 days, the infection would emerge
to become the complete clinical illness of scrub typhus. It should be re-
called that only 36 to 48 hours of chloramphenicol therapy are necessary
for the successful treatment of the clinically apparent scrub typhus. Thus,
in the presence of a fully established infection, 36 to 48 hours of drug
therapy would produce an effect which was not producible when 40 days
of therapy with the sanme drug were given at a.n earlier stage of infection.
This general phenomenon has been further defined in studies with
Q-fever which were reported last May by Drs. Tigertt and Benenson'
before the Association of American Physicians. These investigators were
able to show that 5 days of tetracycline therapy represented perfectly
satisfactory therapy for the treatment of established Q-fever. They also
showed that the incubation period of experimentally induced Q-fever in
man or in the guinea pig could be shortened or lengthened by appropriate
manipulation of the dosage of infective particles. Thus the incubation
period could be quite precisely predicted. In this standardized experimental
situation, they found that 5 days of tetracycline therapy started immedi-
ately after an infection with a predicted incubation period of 12 or 14 days
had no real effect on the subsequent course of events. To be sure, the
incubation period might be extended for a few days beyond that predicted,
but in all cases the subjects developed the complete clinical illness of
Q-fever. The Tigertt-Benenson observations up to this point, therefore,
were the same as the Smadel-Woodward observations on scrub typhus,
and the old clinical inferences from the behavior of infectious syphilis. The
additional information of considerable significance provided by the Tigertt-
Benenson experiment, however, came from the fact that they found that if
the 5 days of tetracycline were given late in the incubation period, immedi-
ately before the anticipated outbreak of the clinical illness, no clinical illness
developed.
Thus there exist five examples of infectious diseases in humans, in which
it has been possible to observe the effectiveness of antimicrobial therapy
started very soon after the inception of infection. In all five examples
(syphilis, malaria, scrub typhus, tuberculosis, Q-fever) the therapy is not
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eradicative, but simply holds the situation "frozen," so to speak, for as long
as its administration is continued. In addition, except possibly for tubercu-
losis, there is evidence from these various diseases that there exists a stage
to which the host-parasite reaction must mature before the infection is fully
drug-susceptible as measured by post-treatment relapse. The Tiggert ob-
servations with Q-fever show that this particular stage of maturity is not
necessarily so old as the stage of evolution to the full clinical illness.
Aside from the possibility of eradication during therapy, the prevention
of post-treatment relapse reflects the extent of the mobilization of certain
host mechanisms that require both the passage of time and a sufficient
"antigenic" stimulus to become fully operative, or the development of cer-
tain evolutionary changes in the parasite. When an increase in numbers
of the infecting population is artificially prevented by administration of an
appropriate drug, any evolutionary changes which might have occurred in
the parasite and the production of a sufficient "antigenic" stimulus are both
hindered. It is important to realize that in these circumstances the infecting
population as a whole cannot be said to be uninfluenced by the drug. For,
the evolution of the infection to overt disease apparently can be arrested
for an indefinite period despite the absence of a sufficient host reaction to
prevent post-treatment relapse. Thus the microbial population may be
regarded as paradoxically being both "drug-influenced" and "drug-indiffer-
ent" at one and the same time.
Presumably what is happening is that a portion of the population is and
remains drug-indifferent. When members of this drug-indifferent group
assume a state of greater drug-susceptibility or are new-born into such a
state, they are presumably immediately incapacitated by the antimicrobial
drug present in the environment. The microbial population as a whole may,
therefore, be said to be in a state of "physiological imprisonment." In this
situation the individual microbes are not eradicated, neither can they evolve
to the point of permitting a host-parasite reaction to develop which would
be susceptible to drug treatment with appreciably less risk of post-treatment
relapse.
In the clinical examples cited this situation apparently obtained from the
moment of infection or soon thereafter. This suggests either that some of
the infecting microbes were drug-indifferent at the time of infection or
became so very shortly thereafter, and that microbial persistence may have
its beginning in the very earliest stages of an infection. If the concept pre-
sented earlier should have validity, namely, that within a few hours of birth
microbial cells may have matured beyond the point of penicillin-suscepti-
bility, every penicillin-susceptible infection would presumably contain mi-
crobes already "drug-indifferent" at the moment of infection. By the same
286
Volume 30, February 1958Microbial persistence MC DERMOTT
token, such phenomena as the relative drug-indifference of microbes held
intracellularly, or the induction of protoplast formation by penicillin ex-
posure, suggest that if microbes are capable of assuming a state of drug-
indifference as an adaptation to their environment, they could do so within
a few moments of infection especially perhaps in the presence of chemo-
prophylaxis.
In actuality, there is no evidence at all on this question of whether certain
cells in a new infection are drug-indifferent right from the beginning or
whether they promptly become so as a response to the new environment
including the antimicrobial drugs therein. As may be inferred from the
foregoing discussion, I believe that both phenomena obtain. The point is
not necessarily an important one, however, because in either case the net
result would be the same and is something which may be of considerable
importance in considerations of chemoprophylaxis.
The actual physical transfer of microbes to a new host is presumably not
always followed by their successful colonization there. In such circum-
stances, the additional inhospitable factor of an antimicrobial drug in the
new environment might well make the difference between the success or
the failure of the implantation. The point for emphasis, however, is the
strong possibility indicated by the considerations presented above, that
even if the appropriate antimicrobial drug is present in the tissue environ-
menit at the momoent of imtplantation, it does not necessarily follow that no
mnicrobes will survive there as persisters. Indeed, from experience in the
penicillin prophylaxis of gonorrhea, when the subject was simultane-
ously exposed to syphilis, there is some evidence that T. pallidum
implanted in the tissues of a host where extracellular fluid contains peni-
cillin can nevertheless survive and eventually give rise to syphilitic infec-
tion. The acquisition of gonorrhea is, to be sure, prevented by the peni-
cillin. But, as mentioned previously, Neisseria represent one of the two
microbial groups that apparently lack the capacity to exhibit microbial
persistence.
To sum up this aspect of the discussion, one must beg the question as to
whether microbial persisters are actively drug-induced or arise only as an
evolutionary adaptation to their environment. What can be reasonably
inferred, however, from the five clinical examples cited and the experience
with "healthy carriers" is: that microbial persistence can occur right from
the early stages of an infection before environmental changes as a conse-
quence of microbial-host interaction would be too advanced, and that in the
examples cited it is clear that the over-all effectiveness of an antimicrobial
drug is at its maximum when the infection is actually producing disease.
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What are the prospects that antimicrobial drugs will be developed which
will abolish microbial persistence-drugs which will be predictably eradica-
tive instead of just being suppressive as is the case with our present drugs?
Thus far, the prospects do not look hopeful. In the first place, the two
microbial groups (Neisseria and B. dysenteriae) which appear to lack the
capacity to persist are apparently eradicated from the tissues by drugs such
as sulfanilamide (Neisseria) or the tetracyclines (B. dysenteriae) neither
among the most powerful of our antimicrobial drugs. In other words, the
eradicative action of these drugs in these infections seems to represent more
the essential fragility of the parasites rather than any qualitatively different
types of drug action. Tubercle bacilli were studied from this standpoint
using the nicotinamide derivative, pyrazinamide. When pyrazinamide and
any one of several antituberculous drugs are administered in appropriate
time-dose relationships to tuberculous mice, the tubercle bacilli completely
vanish from the tissues of the mice and the infection is rendered truly
latent.T By this is meant that it is not possible to detect the presence of the
tubercle bacilli by microscopy, by elaborate culture techniques, or by sub-
inoculation of guinea pigs. To this extent, therefore, the therapy is eradica-
tive. It is easily demonstrated that the infection has not really been eradi-
cated, however, by observing the animals for a 90-day treatment-free in-
terval. When this is done, tubercle bacilli in small numbers can be cultured
from the tissues of approximately 40 per cent of the mice. Moreover, these
microbes are true persisters for as a general rule, they are susceptible to
the drugs involved when subsequently tested in vitro.
In short, microbial persistence may occur at different levels of detect-
ability, yet the phenomenon still endures. Moreover, thus far in the
microbial species studied experimentally the phenomenon has remained
invulnerable despite concerted attacks with all of the available antimicrobial
drugs used singly or in various multiple-drug regimens.
SUMMARY
From certain inferences derived from clinical phenomena and experi-
mental studies in animals, the phenomenon of microbial persistence can be
demonstrated to occur broadly throughout the microbial world. The phe-
nomenon occurs in the absence of antimicrobial therapy, but it is its
occurrence despite antimicrobial therapy that makes understanding of the
phenomenon of such importance in considering treatment failures, post-
treatment relapse, and the chemoprophylaxis of either infection or its sub-
sequent individual manifestations as disease.
As to how the phenomenon of microbial persistence occurs, there is little
if any truly direct evidence. From indirect evidence interpreted specu-
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latively, it appears that microbial persistence is environmentally induced
and is one reflection of a high degree of adaptive plasticity of individual
microbes. It is believed that the range of such types of microbial adaptation
in vivo is substantial and that it is this capacity of individual microbes to
express individuality which determines in large measure the success or the
failure of antimicrobial therapy. An important role of the host defenses in
this process would be to participate in providing "proper" environments
for the adaptive capabilities of the microbe. As the environments represent
the interaction of the host and the parasite, neither can be dismissed from
consideration. It is suggested, however, that perhaps we have been taking
too one-sided a viewpoint in our preoccupation with host mechanisms and
should focus equal attention on this probable wide range of reversible
changes on the part of the microbe.
As host reactions are ad hoc in nature and not necessarily beneficial to
the host as a total organism, the particular environment provided by a host
reaction may or may not lead to a microbial adaptation which favors
maximal drug-susceptibility. Thus the environment of an actively progress-
ing infection may be ideal for the maximal drug-susceptibility of the
microbe, whereas necrotic areas or the interior of phagocytes in the same
host may favor microbial adaptation to assume a state of "drug-indifference."
Viewed in this way, the influence of the inflammatory environment is prob-
ably not exerted by impeding, neutralizing, or enhancing the activity of a
drug, but rather by providing an environment favorable or unfavorable for
the assumption of certain states necessary for drug-susceptibility of the
parasite.
In other words, it is suggested that the nature of the lesion does not
directly influence antimicrobial drug activity. Instead, it is the adaptive
response of the microbe to a particular lesion or a particular host environ-
ment which determines the direction an individual drug-microbe collision
will take. And, it is one manifestation of this adaptive plasticity of the
microbe-the ability to "play dead" so to speak-that determines microbial
persistence and thus provides a means for the survival of microbial species
despite the development of powerful antimicrobial therapies.
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